Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions
Thirlwell, Kayleigh L., Colligan, David, Mountford, Joanne C., Samuel, Kay, Bailey, Laura, Cuesta-Gomez, Nerea, Hewit, Kay D., Kelly, Christopher J, West, Christopher C., McGowan, Neil W.A., Casey, JoVolume:
22
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2020.07.010
Date:
December, 2020
File:
PDF, 2.68 MB
2020